| Property | Value |
|
?:abstract
|
-
Introduction: Understanding the impact of biomarker-based dementia risk estimation in people with mild cognitive impairment (MCI) and their care partners is critical for patient care. Methods: MCI patients and study partners were counseled on Alzheimer's disease (AD) biomarker and dementia risk was disclosed. Data on mood, quality of life (QoL), and satisfaction with life (SwL) were obtained 1 week and 3 months after disclosure. Results: Seventy-five dyads were enrolled, and two-thirds of the patients opted for biomarker testing. None of the participants experienced clinically relevant depression or anxiety after disclosure. All dyads reported moderate to high QoL and SwL throughout the study. Patients reported more subthreshold depressive symptoms 1 week and lower QoL and SwL 3 months after disclosure. In patients, depression (odds ratio [OR]: 0.76) and anxiety (OR: 0.81) were significant predictors for the decision against biomarker testing. Discussion: No major psychological harm is to be expected in MCI patients and care partners after dementia risk disclosure.
(xsd:string)
|
|
?:author
|
|
|
?:comment
|
|
|
?:dataSource
|
-
GESIS-Literaturpool
(xsd:string)
|
|
?:dateModified
|
|
|
?:datePublished
|
|
|
?:doi
|
|
|
?:fromPage
|
|
|
is
?:hasPart
of
|
|
|
?:inLanguage
|
|
|
?:isPartOf
|
|
|
?:issn
|
|
|
?:name
|
-
Psychological outcomes of dementia risk estimation in MCI patients: Results from the PreDADQoL project
(xsd:string)
|
|
?:publicationType
|
|
|
?:sourceInfo
|
-
Bibsonomy
(xsd:string)
-
In Alzheimer's & Dementia, 1-22, 2024
(xsd:string)
|
|
?:tags
|
-
2024
(xsd:string)
-
EX
(xsd:string)
-
GP_contra
(xsd:string)
-
SCIEindexed
(xsd:string)
-
SCOPUSindexed
(xsd:string)
-
ZIS
(xsd:string)
-
ZIS_input2024
(xsd:string)
-
ZIS_pro
(xsd:string)
-
article
(xsd:string)
-
english
(xsd:string)
-
indexproved
(xsd:string)
-
review_proved
(xsd:string)
-
transfer24
(xsd:string)
|
|
?:toPage
|
|
|
rdf:type
|
|
|
?:url
|
|